Exisulind may delay need for hormonal therapy in men with rising PSA.
D000328:Adult; D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D018450:Disease Progression; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013467:Sulindac / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D013467:Sulindac; D017430:Prostate-Specific Antigen; C025463:sulindac sulfone